Skip to main content

Technical View: Nifty forms bullish candle; experts advise booking profit

Mazhar Mohammad of Chartviewindia.in advised traders to book profits and remain neutral on the index.

The Nifty50 opened strong at new record levels and continued its upmove for seventh consecutive session on November 10 following rally in banking & financials stocks.

The progress in vaccine development, positive global cues post Joe Biden's victory in the United States elections and consistent FII inflow supported the market.

The index closed above 12,600 and formed bullish candle which resembles Hanging Man on the daily charts.

A Hanging Man is a bearish reversal candlestick pattern which is usually formed at the end of an uptrend or at the top (around 8.5 percent rally in 7-trading sessions). In a perfect 'Hanging Man' pattern either there will be a small upper shadow or no upper shadow at all, a small body and long lower shadow.

Experts feel the momentum can continue, but if the index breaks 12,475 levels then there could be some correction.

Mazhar Mohammad of Chartviewindia.in advised traders to book profits and remain neutral on the index.

The Nifty50 started off trade on a strong note at 12,556.40 and climbed further to hit an intraday fresh record high of 12,643.90. The index signed off the session at new closing high of 12,631.10, up 170.10 points or 1.37 percent.

"Nifty50 continued its upsurge, perhaps on the back of slew of positive news flows, into the seventh session in a row before signing off the session with a Hanging Man kind of formation as slightly longer lower shadow is visible. Moreover, on a day in which Nifty witnessed strong gains advance decline ratio favoured bears hinting that market participants started profit booking in broader markets by making use of this rally," Mazhar Mohammad, Chief Strategist – Technical Research & Trading Advisory at Chartviewindia.in told Moneycontrol.

However, last 32 sessions of price action may be chalking out an ascending channel which is projecting a possible resistance in the zone of 12,750 – 12,800 levels, he feels.

As momentum oscillators also reaching in extremely overbought levels, some pause or profit-booking can be expected in next one or two trading sessions but as of now weakness will not materialise unless it closes below 12,475 levels, according to him.

India VIX was up by 7.30 percent from 20.11 to 21.57 levels due to higher Call IV.

On option front, maximum Put open interest was at 12,000 followed by 11,000 strike while maximum Call open interest was at 13,000 followed by 13,200 strike. Call writing was seen at 13,500 and 13,200 strike while Put writing was seen at 12,500 then 12,600 strike.



The above-mentioned option data indicated a wider trading range for the Nifty at 12,200 to 13,000 levels.

Bank Nifty opened gap up at 28,039.45 and went on to touch intraday high of 28,800 levels. It closed the session with massive gains of 1,072 points or 3.89 percent at 28,606. Banking stocks have seen continuous buying interest and the index gave the highest close of the last 170 trading sessions.

"The index formed a strong bullish candle on daily scale and has been making higher highs - higher lows from last seven trading sessions. Now it has to continue to hold above 28,000 levels to witness an upmove towards 29,250-29,500 levels," Chandan Taparia, Vice President | Analyst-Derivatives at Motilal Oswal Financial Services said.

Positive setup was seen in Bajaj Finance, M&M Financial, Ashok Leyland, L&T, RBL Bank, LIC Housing Finance, SBI, HDFC, Bharat Forge, ICICI Bank, Apollo Tyres, Motherson Sumi and UltraTech Cement while weakness was seen in Muthoot Finance, Cadila Healthcare, Cipla, Lupin, Mindtree and Aurobindo Pharma.

Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...